Dermata Therapeutics, Inc. (DRMAW) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.15M |
| Enterprise Value | -5.37M |
| P/E Ratio | -0.31 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.59 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.41 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -1.57 |
| Return On Equity | -1.67 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -7.77M |
| Net Income | -7.56M |
| Diluted EPS | -8.16 |
Balance Sheet
| Total Cash | 4.41M |
| Total Cash/Share | 1.1 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 2.81 |
| Book Value Per Share | 0.87 |
Price History
| 52-Week Change | -97.24 |
| 52-Week High | 0.02 |
| 52-Week Low | 0 |
| Moving Average 50 Days | 0.01 |
| Moving Average 200 Days | 0.02 |
Statistics
| Average Volume | 7,234 |
| Shares Outstanding | 681,557 |
| % Held by Institutions | 0.34 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
